(Q33340401)

English

An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 July 2017

An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer (English)

1 reference

Europe PubMed Central

25 July 2017

author name string

Bonnefoi H

1

1 reference

Europe PubMed Central

25 July 2017

Biganzoli L

2

1 reference

Europe PubMed Central

25 July 2017

Cufer T

3

1 reference

Europe PubMed Central

25 July 2017

Mauriac L

4

1 reference

Europe PubMed Central

25 July 2017

Hamilton A

5

1 reference

Europe PubMed Central

25 July 2017

Schaefer P

6

1 reference

Europe PubMed Central

25 July 2017

Piccart M

7

1 reference

Europe PubMed Central

25 July 2017

language of work or name

0 references

publication date

1 November 2001

1 reference

Europe PubMed Central

25 July 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

25 July 2017

70

1 reference

Europe PubMed Central

25 July 2017

1

1 reference

Europe PubMed Central

25 July 2017

55-63

1 reference

Europe PubMed Central

25 July 2017

https://scigraph.springernature.com/pub.10.1023/a:1012530607649

0 references

Phase II study of continuous infusional 5-fluorouracil with epirubicin and carboplatin (instead of cisplatin) in patients with metastatic/locally advanced breast cancer (infusional ECarboF): a very active and well-tolerated outpatient regimen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012530607649

21 January 2018

Randomized phase II trial of infusional fluorouracil, epirubicin, and cyclophosphamide versus infusional fluorouracil, epirubicin, and cisplatin in patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012530607649

21 January 2018

Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012530607649

21 January 2018

Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French Adjuvant Study Group 05 randomized trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012530607649

21 January 2018

Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012530607649

21 January 2018

Weekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012530607649

21 January 2018

Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012530607649

21 January 2018

Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: an active new regimen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012530607649

7 January 2021

based on heuristic

inferred from DOI database lookup

High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012530607649

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012530607649

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012530607649

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012530607649

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012530607649

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012530607649

7 January 2021

based on heuristic

inferred from DOI database lookup

Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012530607649

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot study of intensive cyclophosphamide, epirubicin and fluorouracil in patients with axillary node positive or locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012530607649

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous 5-fluorouracil infusion in refractory carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012530607649

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1012530607649

1 reference

Europe PubMed Central

25 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33340401&oldid=2037304445"